Flibanserin

Trade Name: 
ADDYI
Manufacturer/Distributor: 
Sprout Pharmaceuticals Inc.
Imported by Therapeutics Products Inc
Classification: 
CNS agent
ATC Class: 
G02CX02 - flibanserin
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2018/02/27
Date Marketed in Canada (yyyy/mm/dd): 
2018/02/27
Presentation: 
Tablet: 100 mg. DIN: 02473550
Comments: 
For the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire for a minimum of 6 months, which occurs 75-100% of the time, that causes marked distress or interpersonal difficulty and is NOT due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.
Source: 
Product monograph